Bringing the fundamentals into focus…
Back to AbCellera Biologics Inc.
How AbCellera Biologics Inc. stacks up
ABCL · against 1,216 other Healthcare companies
Growth
84/ 100
Near the top of its peers.
Ranked #190 of 1,217 · scores higher than 84% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including ABCL · Click a bar to see the companies
Why growth scores 84?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
- slower revenue growth over three years: weaker than 95% of peers. 3-year revenue growth: -23.0% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 101.3% vs peer median 6.1%
Metric by metric
Position: dot = ABCL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ABCL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 101.3% | 6.1% | 95% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -23.0% | 5.8% | 5% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ABCL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 178 | 513M USD | 85 | 31 | |
| 178 | 1.9B USD | 85 | 47 | |
| 190 | 672.6B KRW (≈$484M) | 84 | 69 | |
| 190 | 23.0B CNY (≈$3.2B) | 84 | 64 | |
| 190 | 3.9B USD | 84 | 47 | |
| 190 | 222M USD | 84 | 31 | |
| 190 | 40.3B SEK (≈$4.0B) | 84 | 79 | |
| 190 | 1.1B USD | 84 | 50 | |
| 190 | 4.6B USD | 84 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score